TechnoPhage, SA - From science to innovative biopharmaceuticals
Research developed by TechnoPhage, Instituto de Medicina Molecular and Bial featured in news article
Title: Engineered Rabbit Antibody Variable Domains and Uses Thereof Office: European Patent Office Date: 25/03/2015 Patent no: 2164868
Title: Engineered Rabbit Antibody Variable Domains and Uses Thereof Office: Australia Patents Office Date: 16/10/2007 Patent no: 2008246442
TECHNOPHAGE, a biotechnology company headquartered in Lisbon, Portugal, announced today that the company has received authorization from U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for TP-102, a bacteriophage cocktail for the treatment of infected chronic ulcers, namely diabetic foot infections. This clearance will enable TechnoPhage to initiate…